🔗 Share this article Social Media Content Creators Fueling Unofficial Trade for Unlicensed Slimming Medication A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings. Investigational Treatment Acquiring Popularity Via Social Media The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers. Thriving Commerce on Social Networks Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for purchases. Learning About The Experimental Drug Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic. Medical Experts Express Concerns However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin. Some experts stated the popularity for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro. Regulatory Status and Implementation Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012. Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison. Service Response and Material Removal According to the social media company, the platform has taken down violative content and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures. Online Marketplace Operations Research also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence. After moments of joining one community, a seller shared contact information, where most purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage. Product Information and Pricing Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”. Service Oversight and Security Measures A representative for Telegram said it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Medical Professional Warnings “People are injecting substances they can’t verify. Although the science behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained. Her staff has already seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.” Manufacturer Statement A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to potentially significant medical dangers”.